Physiological monitoring device for controlling a medication infusion device
First Claim
1. A method of infusing a fluid into a body of a user comprising:
- operating a physiological monitoring device carried on the exterior of the body of the user, to perform the operations of;
measuring an output signal produced by a sensor, the output signal being a function of a concentration of an analyte in the user;
determining a first amount of time that has elapsed since the sensor provided the output signal;
determining whether the first amount of time exceeds a predetermined amount of time; and
, if the first amount of time does not exceed the predetermined amount of time,calculating an amount of the fluid to be infused into the user'"'"'s body based upon the output signal; and
transmitting a first set of data with a first communication circuit enclosed within a first housing of the physiological monitoring device, the first set of data being indicative of the amount of the fluid to be infused, the first set of data further including an identifier associated with the amount of fluid to be infused;
wherein the amount of fluid to be infused into the user'"'"'s body based upon the output signal is not calculated if the first amount of time exceeds the predetermined amount of time; and
operating a medication infusion device carried on the exterior of the body of the user, to perform the operations of;
receiving the first set of data with a second communication circuit enclosed within a second housing of the medication infusion device carried on the exterior of the body of the user;
verifying the identifier to ensure the amount of fluid to be infused has not already been administered; and
activating a drive mechanism to infuse the fluid in accordance with the first set of data.
0 Assignments
0 Petitions

Accused Products

Abstract
Methods and apparatuses for calculating and transmitting medication dosage or bolus information are provided. A blood glucose meter receives a test strip with a sample of the user'"'"'s blood and measures the user'"'"'s blood glucose level with a sensor. The meter then calculates a bolus amount that is transmitted to a medication infusion pump using a radio frequency transmitter or transceiver. The infusion pump receives the bolus amount data and then delivers a bolus of medication to the user based on the calculated bolus estimate. The meter may also transmit commands to, and be used to remotely control, the infusion pump.
533 Citations
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100094110A1
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device And Methods Of Use | ||
Patent #
US 20100056889A1
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device And Methods Of Use | ||
Patent #
US 20100056891A1
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100099969A1
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268049A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100099968A1
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268048A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100312078A1
Filed 08/18/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100094112A1
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100106001A1
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100100078A1
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090163789A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090171179A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090187088A1
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090177064A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090182212A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090192370A1
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216102A1
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090198175A1
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080262469A1
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070244380A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249919A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Providing COM access to an isolated system | ||
Patent #
US 20070260577A1
Filed 03/30/2006
|
Current Assignee
Microsoft Technology Licensing LLC
|
Original Assignee
Microsoft Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040167801A1
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
PHYSIOLOGICAL SENSOR SYSTEM WITH AUTOMATIC AUTHENTICATION AND VALIDATION BY MEANS OF A RADIO FREQUENCY IDENTIFICATION PROTOCOL WITH AN INTEGRATED RFID INTERROGATOR SYSTEM | ||
Patent #
US 20120098646A1
Filed 12/09/2011
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,287,495 B2
Filed 10/10/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,298,184 B2
Filed 10/11/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Physiological sensor system with automatic authentication and validation by means of a radio frequency identification protocol with an integrated RFID interrogator system | ||
Patent #
US 8,427,321 B2
Filed 12/09/2011
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Insulin pump based expert system | ||
Patent #
US 8,657,779 B2
Filed 05/07/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,721,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
Dex Com Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,758,323 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Automated reservoir fill system | ||
Patent #
US 8,795,231 B2
Filed 05/09/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,808,228 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Activity guard | ||
Patent #
US 8,808,240 B2
Filed 06/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Insulin pump having basal rate testing features | ||
Patent #
US 8,821,433 B2
Filed 05/22/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,882,741 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Physiological sensor system with automatic authentication and validation by means of a Radio Frequency Identification protocol with an integrated RFID interrogator system | ||
Patent #
US 8,896,423 B2
Filed 04/19/2013
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,920,401 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,926,561 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,926,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electronic injector | ||
Patent #
US 8,979,799 B1
Filed 12/19/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
On-body injector and method of use | ||
Patent #
US 8,979,808 B1
Filed 12/19/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Physiological sensor system with automatic authentication and validation by means of a radio frequency identification protocol with an integrated RFID interrogator system | ||
Patent #
US 8,994,553 B2
Filed 02/13/2014
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Aqueous radiation protecting formulations and methods for making and using them | ||
Patent #
US 8,999,720 B2
Filed 10/25/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method and apparatus for continuous analyte monitoring | ||
Patent #
US 9,008,744 B2
Filed 05/06/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,050,413 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Secure communication by user selectable communication range | ||
Patent #
US 9,143,941 B2
Filed 12/18/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,155,843 B2
Filed 07/26/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,211,377 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,213,010 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor systems having multiple probes and electrode arrays | ||
Patent #
US 9,215,995 B2
Filed 06/21/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
ICE message system and method | ||
Patent #
US 9,226,709 B2
Filed 11/04/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
On-body injector and method of use | ||
Patent #
US 9,265,884 B2
Filed 02/04/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Therapeutic agent injection device | ||
Patent #
US 9,265,881 B2
Filed 10/14/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and systems for optimizing sensor function by the application of voltage | ||
Patent #
US 9,265,455 B2
Filed 11/13/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Accelerated life testing device and method | ||
Patent #
US 9,267,875 B2
Filed 11/21/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Variable data usage personal medical system and method | ||
Patent #
US 9,338,819 B2
Filed 05/29/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,357,958 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Short message service (SMS)-enabled open automated demand response (OpenADR) server and related communications systems and methods | ||
Patent #
US 9,369,305 B1
Filed 01/11/2013
|
Current Assignee
IPKeys Power Partners LLC
|
Original Assignee
IPKeys Technologies
|
Therapeutic agent injection device | ||
Patent #
US 9,375,537 B2
Filed 09/19/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Medication pump test device and method of use | ||
Patent #
US 9,388,805 B2
Filed 03/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,408,567 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Physiological sensor system with automatic authentication and validation by means of a radio frequency identification protocol with an integrated RFID interrogator system | ||
Patent #
US 9,411,995 B2
Filed 02/23/2015
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Methods for making an aqueous radiation protecting formulation | ||
Patent #
US 9,421,287 B2
Filed 03/05/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,452,258 B2
Filed 10/09/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Smart connection interface | ||
Patent #
US 9,452,255 B2
Filed 07/16/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,452,256 B2
Filed 07/20/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,452,259 B2
Filed 10/25/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,457,146 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,463,277 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for providing closed loop infusion formulation delivery | ||
Patent #
US 9,480,796 B2
Filed 06/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Safety processor for wireless control of a drug delivery device | ||
Patent #
US 9,486,571 B2
Filed 12/23/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Foldover sensors and methods for making and using them | ||
Patent #
US 9,493,807 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Smart connection interface | ||
Patent #
US 9,517,299 B2
Filed 07/20/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Microprocessor controlled ambulatory medical apparatus with hand held communication device | ||
Patent #
US 9,533,096 B2
Filed 10/30/2014
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
On-body injector and method of use | ||
Patent #
US 9,539,386 B2
Filed 01/15/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
On-body injector and method of use | ||
Patent #
US 9,545,477 B2
Filed 01/15/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System and method for detecting and transmitting medical device alarm with a smartphone application | ||
Patent #
US 9,565,718 B2
Filed 09/10/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,572,936 B2
Filed 10/25/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,572,935 B2
Filed 10/25/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,586,004 B2
Filed 10/25/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insulin pump data acquisition device | ||
Patent #
US 9,592,335 B2
Filed 10/20/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,597,453 B2
Filed 10/25/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 9,603,561 B2
Filed 04/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,625,414 B2
Filed 11/05/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,625,415 B2
Filed 05/13/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,632,060 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,645,111 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 9,649,059 B2
Filed 04/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 9,649,058 B2
Filed 04/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Short message service (SMS)-enabled open automated demand response (OpenADR) server and related communications systems and methods | ||
Patent #
US 9,667,578 B2
Filed 06/13/2016
|
Current Assignee
IPKeys Power Partners LLC
|
Original Assignee
IPKeys Technologies
|
Reservoir fluid volume estimator and medical device incorporating same | ||
Patent #
US 9,682,188 B2
Filed 11/26/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor detection pads with integrated fuse | ||
Patent #
US 9,689,830 B2
Filed 04/03/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement | ||
Patent #
US 9,693,720 B2
Filed 04/17/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Priming detection system and method of using the same | ||
Patent #
US 9,707,336 B2
Filed 04/07/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Data derived pre-bolus delivery | ||
Patent #
US 9,717,848 B2
Filed 01/22/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Geofencing for medical devices | ||
Patent #
US 9,717,845 B2
Filed 08/19/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Medication pump test device and method of use | ||
Patent #
US 9,719,505 B2
Filed 06/14/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Mechanical injection pump and method of use | ||
Patent #
US 9,731,067 B2
Filed 11/25/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integration of infusion pump with remote electronic device | ||
Patent #
US 9,737,656 B2
Filed 12/26/2014
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Smart connection interface | ||
Patent #
US 9,744,291 B2
Filed 11/04/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,744,290 B2
Filed 11/04/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Dry insertion and one-point in vivo calibration of an optical analyte sensor | ||
Patent #
US 9,757,057 B2
Filed 11/06/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Personal medical device and method of use with restricted mode challenge | ||
Patent #
US 9,757,511 B2
Filed 10/19/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Fingerprint enhanced authentication for medical devices in wireless networks | ||
Patent #
US 9,779,226 B2
Filed 12/18/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,789,245 B2
Filed 11/04/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Intelligent therapy recommendation algorithim and method of using the same | ||
Patent #
US 9,795,738 B2
Filed 05/10/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,801,576 B2
Filed 03/01/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,808,191 B2
Filed 03/08/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 9,827,372 B2
Filed 11/28/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical systems and methods for ratiometric measurement of blood glucose concentration | ||
Patent #
US 9,839,378 B2
Filed 08/07/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Insulin pump data acquisition device and system | ||
Patent #
US 9,841,014 B2
Filed 05/11/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Biostable glucose permeable polymer | ||
Patent #
US 9,848,805 B2
Filed 12/18/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,861,746 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,863,911 B2
Filed 08/02/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Belt clip | ||
Patent #
US 9,872,954 B2
Filed 03/02/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Accelerated life testing device and method | ||
Patent #
US 9,885,650 B2
Filed 01/15/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Physiological sensor history backfill system and method | ||
Patent #
US 9,901,305 B2
Filed 06/13/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion set insertion device and method of use | ||
Patent #
US 9,901,675 B2
Filed 11/25/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,925,330 B2
Filed 07/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,931,460 B2
Filed 07/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 9,931,459 B2
Filed 07/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,937,293 B2
Filed 08/19/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 9,943,256 B2
Filed 04/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System and method for detecting occlusions in an infusion pump | ||
Patent #
US 9,962,486 B2
Filed 11/02/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Systems for set connector assembly with lock | ||
Patent #
US 9,968,737 B2
Filed 05/26/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods, systems, and devices for electrode capacitance calculation and application | ||
Patent #
US 9,970,893 B2
Filed 04/28/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Therapeutic agent injection device | ||
Patent #
US 9,987,476 B2
Filed 05/27/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and materials for modulating start-up time and air removal in dry sensors | ||
Patent #
US 9,989,522 B2
Filed 05/23/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,989,490 B2
Filed 02/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 9,989,491 B2
Filed 03/29/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Protocol translation device | ||
Patent #
US 9,992,818 B2
Filed 10/06/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Regulating entry into a closed-loop operating mode of an insulin infusion system | ||
Patent #
US 9,999,728 B2
Filed 04/19/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Advanced step therapy delivery for an ambulatory infusion pump and system | ||
Patent #
US 10,016,559 B2
Filed 10/28/2014
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 10,039,479 B2
Filed 02/09/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System for monitoring physiological characteristics | ||
Patent #
US 10,080,529 B2
Filed 01/16/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems for set connector assembly with lock | ||
Patent #
US 10,086,134 B2
Filed 05/26/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems for set connector assembly with lock | ||
Patent #
US 10,086,133 B2
Filed 05/26/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Time averaged basal rate optimizer | ||
Patent #
US 10,112,011 B2
Filed 06/17/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for leakage detection in portable medical devices | ||
Patent #
US 10,130,757 B2
Filed 05/01/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,156,543 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,166,327 B2
Filed 02/14/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,172,544 B2
Filed 09/12/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,172,998 B2
Filed 02/14/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,172,999 B2
Filed 02/14/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Microarray electrodes useful with analyte sensors and methods for making and using them | ||
Patent #
US 10,194,840 B2
Filed 12/06/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Anchoring apparatus and method for attaching device on body | ||
Patent #
US 10,194,864 B2
Filed 06/21/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Safety processor for a drug delivery device | ||
Patent #
US 10,213,547 B2
Filed 10/28/2016
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and apparatus for electronic patient care | ||
Patent #
US 10,242,159 B2
Filed 03/15/2013
|
Current Assignee
Deka Products Limited Partnership
|
Original Assignee
Deka Products Limited Partnership
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 10,258,264 B2
Filed 04/10/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Systems including vial adapter for fluid transfer | ||
Patent #
US 10,258,736 B2
Filed 01/04/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Belt clip | ||
Patent #
US 10,265,465 B2
Filed 01/10/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,278,580 B2
Filed 06/09/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems for managing reservoir chamber pressure | ||
Patent #
US 10,279,128 B2
Filed 11/13/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Fluid infusion device and related sealing assembly for a needleless fluid reservoir | ||
Patent #
US 10,300,264 B2
Filed 03/14/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,321,865 B2
Filed 11/17/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
In-vivo electrochemical impedance spectroscopy (EIS)-based calibration | ||
Patent #
US 10,321,844 B2
Filed 08/22/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
In-situ chemistry stack for continuous glucose sensors | ||
Patent #
US 10,324,058 B2
Filed 04/28/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them | ||
Patent #
US 10,327,678 B2
Filed 04/08/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor systems, devices, and methods for continuous glucose monitoring | ||
Patent #
US 10,327,686 B2
Filed 12/28/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor systems, devices, and methods for continuous glucose monitoring | ||
Patent #
US 10,327,680 B2
Filed 12/28/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,335,076 B2
Filed 11/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,335,077 B2
Filed 11/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,342,468 B2
Filed 11/20/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Hand-held device housing | ||
Patent #
US D853,583 S1
Filed 03/29/2017
|
Current Assignee
Becton Dickinson Co
|
Original Assignee
Becton Dickinson Co
|
Methods, systems, and devices for sensor fusion | ||
Patent #
US 10,349,872 B2
Filed 12/28/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrom-bogenic agent | ||
Patent #
US 10,352,941 B2
Filed 09/25/2012
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Advance diagnosis of infusion device operating mode viability | ||
Patent #
US 10,363,366 B2
Filed 03/22/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,376,632 B2
Filed 11/08/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,376,631 B2
Filed 11/08/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Insertion device | ||
Patent #
US 10,413,183 B2
Filed 11/21/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Detecting breakage in a display element | ||
Patent #
US 10,417,946 B2
Filed 06/25/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor connections | ||
Patent #
US 10,420,508 B2
Filed 11/21/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating | ||
Patent #
US 10,426,383 B2
Filed 02/27/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods and systems for improving the reliability of orthogonally redundant sensors | ||
Patent #
US 10,426,385 B2
Filed 04/07/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Methods, systems, and devices for electrode capacitance calculation and application | ||
Patent #
US 10,426,389 B2
Filed 04/28/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 10,434,253 B2
Filed 11/01/2016
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Pump clip for a fluid infusion device | ||
Patent #
US 10,449,291 B2
Filed 08/29/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System, method, and apparatus for electronic patient care | ||
Patent #
US 10,453,157 B2
Filed 12/21/2011
|
Current Assignee
Deka Products Limited Partnership
|
Original Assignee
Deka Products Limited Partnership
|
Protocol translation device | ||
Patent #
US 10,455,639 B2
Filed 05/04/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integration of infusion pump with remote electronic device | ||
Patent #
US 10,478,551 B2
Filed 07/19/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Monitoring the operating health of a force sensor in a fluid infusion device | ||
Patent #
US 10,478,554 B2
Filed 08/21/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Pump clip for a fluid infusion device | ||
Patent #
US 10,485,924 B2
Filed 08/29/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Medical devices with microneedle arrays and methods for operating such medical devices | ||
Patent #
US 10,524,730 B2
Filed 09/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Data modification for predictive operations and devices incorporating same | ||
Patent #
US 10,525,200 B2
Filed 11/21/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Microneedle arrays and methods for fabricating microneedle arrays | ||
Patent #
US 10,525,244 B2
Filed 09/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Geofencing for medical devices | ||
Patent #
US 10,532,156 B2
Filed 06/23/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Insertion device for insertion set | ||
Patent #
US 10,532,153 B2
Filed 05/31/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,532,150 B2
Filed 07/16/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Automated reservoir fill system | ||
Patent #
US 10,532,835 B2
Filed 06/24/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
System and method for providing closed loop infusion formulation delivery | ||
Patent #
US 10,549,036 B2
Filed 09/30/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
User-configurable closed-loop notifications and infusion systems incorporating same | ||
Patent #
US 10,561,789 B2
Filed 11/30/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Adhesive patch arrangement for a physiological characteristic sensor, and related sensor assembly | ||
Patent #
US 10,596,295 B2
Filed 08/28/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Error handling in infusion devices with distributed motor control and related operating methods | ||
Patent #
US 10,617,816 B2
Filed 05/16/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor detection pads with integrated fuse | ||
Patent #
US 10,620,149 B2
Filed 05/25/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor and transmitter product | ||
Patent #
US 10,631,787 B2
Filed 11/21/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Use of electrochemical impedance spectroscopy (EIS) in intelligent diagnostics | ||
Patent #
US 10,638,947 B2
Filed 08/22/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Application of electrochemical impedance spectroscopy in sensor systems, devices, and related methods | ||
Patent #
US 10,660,555 B2
Filed 05/22/2019
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Medication fluid infusion set component with integrated physiological analyte sensor, and corresponding fluid infusion device | ||
Patent #
US 10,709,834 B2
Filed 12/14/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensor | ||
Patent #
US 10,765,369 B2
Filed 04/03/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor and transmitter product | ||
Patent #
US 10,765,348 B2
Filed 04/03/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Microarray electrodes useful with analyte sensors and methods for making and using them | ||
Patent #
US 10,772,540 B2
Filed 01/07/2019
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Fingerprint enhanced authentication for medical devices in wireless networks | ||
Patent #
US 10,776,466 B2
Filed 08/25/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Wireless control of a drug delivery device | ||
Patent #
US 10,806,851 B2
Filed 02/12/2019
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Original Assignee
Tandem Diabetes Care Incorporated
|
Physiological sensor history backfill system and method | ||
Patent #
US 10,813,592 B2
Filed 02/03/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Smart connection interface | ||
Patent #
US 10,821,222 B2
Filed 07/16/2015
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Time averaged basal rate optimizer | ||
Patent #
US 10,821,229 B2
Filed 09/27/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Cannulas for drug delivery devices | ||
Patent #
US 10,821,225 B2
Filed 12/21/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor set | ||
Patent #
US 10,827,959 B2
Filed 11/09/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor set | ||
Patent #
US 10,827,960 B2
Filed 08/01/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Measurement of fluid delivery | ||
Patent #
US 10,830,785 B1
Filed 07/27/2020
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Therapeutic agent injection device | ||
Patent #
US 10,835,727 B2
Filed 05/30/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insertion site monitoring methods and related infusion devices and systems | ||
Patent #
US 10,842,936 B2
Filed 03/08/2019
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Physiological characteristic sensors and methods for forming such sensors | ||
Patent #
US 10,845,330 B2
Filed 05/15/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Predicted time to assess and/or control a glycemic state | ||
Patent #
US 10,850,033 B2
Filed 08/01/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion systems and related personalized bolusing methods | ||
Patent #
US 10,854,323 B2
Filed 12/19/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion systems and methods for patient activity adjustments | ||
Patent #
US 10,854,322 B2
Filed 12/19/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Sensor initialization methods for faster body sensor response | ||
Patent #
US 10,856,784 B2
Filed 06/30/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Proactive image-based infusion device delivery adjustments | ||
Patent #
US 10,861,603 B2
Filed 05/03/2019
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion systems and methods for pattern-based therapy adjustments | ||
Patent #
US 10,861,591 B2
Filed 12/19/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electronic patient monitoring system | ||
Patent #
US 10,872,685 B2
Filed 08/20/2013
|
Current Assignee
Deka Products Limited Partnership
|
Original Assignee
Deka Products Limited Partnership
|
Waferscale physiological characteristic sensor package with integrated wireless transmitter | ||
Patent #
US 10,874,300 B2
Filed 09/26/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion devices and related rescue detection methods | ||
Patent #
US 10,894,125 B2
Filed 10/16/2018
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Fluid infusion system that automatically determines and delivers a correction bolus | ||
Patent #
US 10,894,126 B2
Filed 02/13/2019
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Computerized medical diagnostic and treatment advice system | ||
Patent #
US 5,868,669 A
Filed 01/09/1997
|
Current Assignee
Clinical Decision Support LLC
|
Original Assignee
First Opinion Corporation
|
Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game | ||
Patent #
US 5,913,310 A
Filed 10/29/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Method and apparatus for coordinating transfer of information between a base station and a plurality of radios | ||
Patent #
US 5,499,243 A
Filed 01/22/1993
|
Current Assignee
Dennis R. Hall
|
Original Assignee
Dennis R. Hall
|
Drug pump systems and methods | ||
Patent #
US 5,935,099 A
Filed 01/10/1997
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
SIMS DELTEC INC.
|
Networked system for interactive communication and remote monitoring of individuals | ||
Patent #
US 5,997,476 A
Filed 10/07/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,997,920 B2
Filed 03/27/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 7,025,743 B2
Filed 03/27/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,872,200 B2
Filed 03/27/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 6,881,551 B2
Filed 01/28/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Biosensor | ||
Patent #
US 6,893,545 B2
Filed 11/25/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Device and method employing shape memory alloy | ||
Patent #
US 6,916,159 B2
Filed 10/09/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,936,029 B2
Filed 01/31/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Infusion device and driving mechanism and process for same with actuator for multiple infusion uses | ||
Patent #
US 6,932,584 B2
Filed 12/26/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Biosensor membranes composed of polymers containing heterocyclic nitrogens | ||
Patent #
US 6,932,894 B2
Filed 05/14/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,942,518 B2
Filed 12/28/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Anti-ferromagnetically coupled granular-continuous magnetic recording media | ||
Patent #
US 20050214585A1
Filed 03/23/2004
|
Current Assignee
Seagate Technology LLC
|
Original Assignee
Seagate Technology LLC
|
Infusion device and driving mechanism and process for same with actuator for multiple infusion uses | ||
Patent #
US 6,945,760 B2
Filed 08/23/2004
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,979,326 B2
Filed 03/27/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes | ||
Patent #
US 6,676,816 B2
Filed 05/09/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Electrochemical analyte sensors using thermostable soybean peroxidase | ||
Patent #
US 6,689,265 B2
Filed 03/23/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Medical apparatus with remote control | ||
Patent #
US 6,689,091 B2
Filed 01/03/2002
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
Method and apparatus for enhancing the integrity of an implantable sensor device | ||
Patent #
US 20040064156A1
Filed 12/31/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
High reliability multlayer circuit substrates and methods for their formation | ||
Patent #
US 20040061234A1
Filed 09/26/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte sensors and methods for making them | ||
Patent #
US 20040074785A1
Filed 10/18/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Multilayer substrate | ||
Patent #
US 20040061232A1
Filed 12/26/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Implantable sensor method and system | ||
Patent #
US 20040064133A1
Filed 12/31/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic-Minimed
|
Hemostatic system and components for extracorporeal circuit | ||
Patent #
US 6,733,471 B1
Filed 09/15/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte detection system with software download capabilities | ||
Patent #
US 20040093167A1
Filed 11/08/2002
|
Current Assignee
OptiScan Biomedical Corporation
|
Original Assignee
Hercules Technology Growth Capital Inc.
|
Electrodes with multilayer membranes and methods of making the electrodes | ||
Patent #
US 6,746,582 B2
Filed 05/11/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Mass transport limited in vivo analyte sensor | ||
Patent #
US 20040111017A1
Filed 11/25/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,749,740 B2
Filed 12/28/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Telemetered characteristic monitor system and method of using the same | ||
Patent #
US 6,809,653 B1
Filed 12/17/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Biosensor | ||
Patent #
US 6,503,381 B1
Filed 09/18/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 6,514,718 B2
Filed 11/29/2001
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
User state sensitive system and method for nutrient analysis using natural language interface | ||
Patent #
US 6,556,963 B1
Filed 09/24/1997
|
Current Assignee
International Business Machines Corporation
|
Original Assignee
International Business Machines Corporation
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,554,798 B1
Filed 06/16/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
External infusion device with remote programming bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 6,551,276 B1
Filed 12/17/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Method and system for non-vascular sensor implantation | ||
Patent #
US 20030078560A1
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,565,509 B1
Filed 09/21/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Handheld personal data assistant (PDA) with a medical device and method of using the same | ||
Patent #
US 6,558,320 B1
Filed 01/20/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electrochemical analyte sensor | ||
Patent #
US 20030088166A1
Filed 11/11/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,560,471 B1
Filed 01/02/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Blood analyte monitoring through subcutaneous measurement | ||
Patent #
US 6,579,690 B1
Filed 07/24/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Microprocessor controlled ambulatory medical apparatus with hand held communication device | ||
Patent #
US 6,577,899 B2
Filed 01/22/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 6,591,125 B1
Filed 06/27/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 6,592,745 B1
Filed 05/17/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Biological fuel cell and methods | ||
Patent #
US 20030152823A1
Filed 03/10/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith | ||
Patent #
US 6,605,201 B1
Filed 11/14/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Polymeric transition metal complexes and uses thereof | ||
Patent #
US 6,605,200 B1
Filed 11/14/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Integrated lancing and measurement device and analyte measuring methods | ||
Patent #
US 6,607,658 B1
Filed 11/15/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Reusable ceramic skin-piercing device | ||
Patent #
US 6,623,501 B2
Filed 04/05/2001
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 20030176183A1
Filed 03/29/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor and methods | ||
Patent #
US 6,616,819 B1
Filed 11/04/1999
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Method of manufacturing small volume in vitro analyte sensor | ||
Patent #
US 6,618,934 B1
Filed 06/15/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking | ||
Patent #
US 20030168338A1
Filed 09/19/2002
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Process for producing an electrochemical biosensor | ||
Patent #
US 20030188427A1
Filed 03/31/2003
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 20030199744A1
Filed 04/17/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Mass transport limited in vivo analyte sensor | ||
Patent #
US 6,654,625 B1
Filed 06/16/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Reusable analyte sensor site and method of using the same | ||
Patent #
US 20030220552A1
Filed 02/12/2003
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Handheld personal data assistant (PDA) with a medical device and method of using the same | ||
Patent #
US 6,641,533 B2
Filed 08/23/2001
|
Current Assignee
Minimed Inc.
|
Original Assignee
Medtronic Minimed Incorporated
|
Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same | ||
Patent #
US 6,671,554 B2
Filed 12/27/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Microprocessor controlled ambulatory medical apparatus with hand held communication device | ||
Patent #
US 20020019606A1
Filed 01/22/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Remotely programmable infusion system | ||
Patent #
US 6,355,018 B1
Filed 07/27/2000
|
Current Assignee
Kimberly-Clark Worldwide Incorporated
|
Original Assignee
I-Flow Corporation
|
System and method of communicating between an implantable medical device and a remote computer system or health care provider | ||
Patent #
US 20020082665A1
Filed 01/18/2001
|
Current Assignee
Rosellini Scientific Benelux SPRL
|
Original Assignee
Medtronic Incorporated
|
Method of applying insulation for coating implantable components and other microminiature devices | ||
Patent #
US 6,472,122 B1
Filed 09/09/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Device and method for infusion of small molecule insulin mimetic materials | ||
Patent #
US 6,461,331 B1
Filed 05/08/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Real time self-adjusting calibration algorithm | ||
Patent #
US 20020161288A1
Filed 05/08/2002
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Electrochemical analyte sensor | ||
Patent #
US 6,484,046 B1
Filed 07/10/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Automated delivery device and method for its operation | ||
Patent #
US 6,171,276 B1
Filed 08/05/1998
|
Current Assignee
Pharmacia AB
|
Original Assignee
Pharmacia Upjohn AB
|
Analyte monitoring device and methods of use | ||
Patent #
US 6,175,752 B1
Filed 04/30/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Multiple patient monitoring system for proactive health management | ||
Patent #
US 6,246,992 B1
Filed 09/14/1998
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
System and method for transferring information relating to an implantable medical device to a remote location | ||
Patent #
US 6,250,309 B1
Filed 07/21/1999
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte sensor and holter-type monitor system and method of using the same | ||
Patent #
US 6,248,067 B1
Filed 02/05/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Method and kit for supplying a fluid to a subcutaneous placement site | ||
Patent #
US 6,254,586 B1
Filed 09/14/1999
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Implantable substrate sensor | ||
Patent #
US 6,259,937 B1
Filed 06/19/1998
|
Current Assignee
AFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Infusion pump with an electronically loadable drug library and a user interface for loading the library | ||
Patent #
US 6,269,340 B1
Filed 10/27/1997
|
Current Assignee
General Hospital Corporation, Baxter International Inc.
|
Original Assignee
General Hospital Corporation, Baxter International Inc.
|
Patient-controlled medication delivery system | ||
Patent #
US 6,270,481 B1
Filed 06/16/1999
|
Current Assignee
LMA North America Incorporated
|
Original Assignee
Breg Incorporated
|
Infusion pump system and an infusion pump unit | ||
Patent #
US 6,270,478 B1
Filed 04/03/2000
|
Current Assignee
Bigfoot Biomedical Inc.
|
Original Assignee
Merne Morton
|
Measurement apparatus | ||
Patent #
US 6,295,506 B1
Filed 10/23/1998
|
Current Assignee
Nokia US Holdings. Inc.
|
Original Assignee
Nokia Mobile Phones UK Limited
|
Subcutaneous glucose electrode | ||
Patent #
US 6,329,161 B1
Filed 09/22/2000
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Personalized display of health information | ||
Patent #
US 6,032,119 A
Filed 01/16/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Alumina insulation for coating implantable components and other microminiature devices | ||
Patent #
US 6,043,437 A
Filed 12/19/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Implantable device with improved battery recharging and powering configuration | ||
Patent #
US 6,067,474 A
Filed 07/31/1998
|
Current Assignee
Advanced Bionics
|
Original Assignee
Advanced Bionics Corporation, Alfred E. Mann Foundation For Scientific Research
|
Implantable enzyme-based monitoring systems adapted for long term use | ||
Patent #
US 6,081,736 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical sensor and integrity tests therefor | ||
Patent #
US 6,088,608 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical analyte measurement system | ||
Patent #
US 6,083,710 A
Filed 06/16/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Multi-user remote health monitoring system | ||
Patent #
US 6,101,478 A
Filed 11/21/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Process for producing an electrochemical biosensor | ||
Patent #
US 6,103,033 A
Filed 03/04/1998
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Electrochemical analyte measurement system | ||
Patent #
US 6,121,009 A
Filed 07/16/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Method of using a small volume in vitro analyte sensor | ||
Patent #
US 6,120,676 A
Filed 06/04/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
Therasense Incorporated
|
Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces | ||
Patent #
US 6,119,028 A
Filed 10/20/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Electrochemical analyte | ||
Patent #
US 6,134,461 A
Filed 03/04/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Apparatus for monitoring and/or controlling a medical device | ||
Patent #
US 6,135,949 A
Filed 09/14/1998
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
Small volume in vitro analyte sensor | ||
Patent #
US 6,143,164 A
Filed 12/16/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Air bubble sensor | ||
Patent #
US 6,142,008 A
Filed 06/12/1998
|
Current Assignee
ICU Medical Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 6,162,611 A
Filed 01/03/2000
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Ultrasound transdermal communication system and method | ||
Patent #
US 5,861,018 A
Filed 05/28/1996
|
Current Assignee
TELECOM MEDICAL INC.
|
Original Assignee
TELECOM MEDICAL INC.
|
Remotely programmable infusion system | ||
Patent #
US 5,871,465 A
Filed 06/05/1996
|
Current Assignee
Kimberly-Clark Worldwide Incorporated
|
Original Assignee
I-Flow Corporation
|
Medical apparatus with remote virtual input device | ||
Patent #
US 5,885,245 A
Filed 10/16/1997
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Sabratek Corp.
|
On-line health education and feedback system using motivational driver profile coding and automated content fulfillment | ||
Patent #
US 5,879,163 A
Filed 06/24/1996
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Monitoring system for remotely querying individuals | ||
Patent #
US 5,897,493 A
Filed 04/30/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
System and method for deriving relative physiologic signals | ||
Patent #
US 5,904,708 A
Filed 03/19/1998
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Modular microprocessor-based health monitoring system | ||
Patent #
US 5,899,855 A
Filed 06/07/1995
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Low power current to frequency converter circuit for use in implantable sensors | ||
Patent #
US 5,917,346 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Method for treating medical conditions using a microprocessor-based video game | ||
Patent #
US 5,918,603 A
Filed 05/15/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Medication delivery device with a microprocessor and characteristic monitor | ||
Patent #
US 5,925,021 A
Filed 07/24/1997
|
Current Assignee
Becton Dickinson Co
|
Original Assignee
Visionary Medical Systems Incorporated
|
Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions | ||
Patent #
US 5,940,801 A
Filed 07/31/1998
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Network media access control system for encouraging patient compliance with a treatment plan | ||
Patent #
US 5,933,136 A
Filed 12/23/1996
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site | ||
Patent #
US 5,951,521 A
Filed 09/25/1998
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Health management process control system | ||
Patent #
US 5,960,403 A
Filed 08/19/1998
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Disease simulation system and method | ||
Patent #
US 5,956,501 A
Filed 01/10/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Electrochemical analyte sensors using thermostable peroxidase | ||
Patent #
US 5,972,199 A
Filed 02/11/1997
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. Heller Company
|
Subcutaneous glucose electrode | ||
Patent #
US 5,965,380 A
Filed 01/12/1999
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Noninvasive apparatus having a retaining member to retain a removable biosensor | ||
Patent #
US 5,961,451 A
Filed 04/07/1997
|
Current Assignee
William Reber LLC
|
Original Assignee
Motorola Inc.
|
Low power rectifier circuit for implantable medical device | ||
Patent #
US 5,999,849 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Daisy chainable sensors and stimulators for implantation in living tissue | ||
Patent #
US 5,999,848 A
Filed 09/12/1997
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Blood parameter measurement device | ||
Patent #
US 6,009,339 A
Filed 02/27/1997
|
Current Assignee
Terumo Cardiovascular Systems Corporation
|
Original Assignee
Terumo Cardiovascular Systems Corporation
|
System for monitoring and reporting medical measurements | ||
Patent #
US 5,704,366 A
Filed 05/23/1994
|
Current Assignee
Nortek Security Control LLC
|
Original Assignee
ENACT HEALTH MANAGEMENT SYSTEMS
|
Modular patient care system | ||
Patent #
US 5,713,856 A
Filed 03/13/1995
|
Current Assignee
Carefusion 303 Incorporated
|
Original Assignee
ALARIS Medical Systems Inc.
|
Two-way TDMA telemetry system with power conservation features | ||
Patent #
US 5,748,103 A
Filed 07/09/1996
|
Current Assignee
GE Medical Systems Information Technologies Incorporated
|
Original Assignee
VitalCom Inc.
|
Hermetically sealed electrical feedthrough for use with implantable electronic devices | ||
Patent #
US 5,750,926 A
Filed 08/16/1995
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Apparatus for remotely monitoring controllable devices | ||
Patent #
US 5,764,159 A
Filed 08/02/1996
|
Current Assignee
Debiotech S.A.
|
Original Assignee
Debiotech S.A.
|
Automated infusion system with dose rate calculator | ||
Patent #
US 5,772,635 A
Filed 05/15/1995
|
Current Assignee
Carefusion 303 Incorporated
|
Original Assignee
ALARIS Medical Systems Inc.
|
Hydrophilic, swellable coatings for biosensors | ||
Patent #
US 5,786,439 A
Filed 10/24/1996
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Silicon-containing biocompatible membranes | ||
Patent #
US 5,777,060 A
Filed 09/26/1996
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Transdermal introducer assembly | ||
Patent #
US 5,779,665 A
Filed 05/08/1997
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Pump tracking system | ||
Patent #
US 5,788,669 A
Filed 11/22/1995
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
SIMS DELTEC INC.
|
Patient monitoring system | ||
Patent #
US 5,791,344 A
Filed 01/04/1996
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Apparatus for monitoring and/or controlling a medical device | ||
Patent #
US 5,807,336 A
Filed 08/02/1996
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Sabratek Corp.
|
Infusion pump for at least one syringe | ||
Patent #
US 5,814,015 A
Filed 02/24/1995
|
Current Assignee
Carefusion 303 Incorporated
|
Original Assignee
Shuta Hamada
|
Multiple patient monitoring system for proactive health management | ||
Patent #
US 5,832,448 A
Filed 10/16/1996
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Monitoring method and a monitoring equipment | ||
Patent #
US 5,840,020 A
Filed 02/05/1997
|
Current Assignee
Nokia Technologies Oy
|
Original Assignee
Nokia Mobile Phones UK Limited
|
Patient specific dosing contrast delivery systems and methods | ||
Patent #
US 5,840,026 A
Filed 09/21/1994
|
Current Assignee
Bayer Healthcare LLC
|
Original Assignee
Medrad Incorporated
|
Subcutaneous glucose electrode | ||
Patent #
US 5,593,852 A
Filed 09/01/1994
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Adam Heller, Michael V. Pishko
|
Computerized medical diagnostic system including re-enter function and sensitivity factors | ||
Patent #
US 5,594,638 A
Filed 12/29/1993
|
Current Assignee
Clinical Decision Support LLC
|
Original Assignee
First Opinion Corporation
|
Medication delivery device with a microprocessor and characteristic monitor | ||
Patent #
US 5,593,390 A
Filed 02/28/1995
|
Current Assignee
Becton Dickinson Co
|
Original Assignee
Visionary Medical Systems Incorporated
|
Infusion pump and method with dose-rate calculation | ||
Patent #
US 5,609,575 A
Filed 04/04/1995
|
Current Assignee
Graseby Medical Limited
|
Original Assignee
Graseby Medical Limited
|
Multiple channel perfused manometry apparatus and a method of operation of such a device | ||
Patent #
US 5,609,060 A
Filed 04/28/1995
|
Current Assignee
DENTSLEEVE PTY LIMITED
|
Original Assignee
DENTSLEEVE PTY LIMITED
|
Infusion pump with dual-latching mechanism | ||
Patent #
US 5,620,312 A
Filed 03/06/1995
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Sabratek Corp.
|
Infusion system with air-in-line clear function | ||
Patent #
US 5,616,124 A
Filed 01/13/1995
|
Current Assignee
Carefusion 303 Incorporated
|
Original Assignee
IVAC Medical Systems Inc.
|
Ambulatory infusion pump | ||
Patent #
US 5,630,710 A
Filed 03/09/1994
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
System for monitoring and reporting medical measurements | ||
Patent #
US 5,626,144 A
Filed 12/22/1995
|
Current Assignee
ENACT HEALTH MANAGEMENT SYSTEMS
|
Original Assignee
ENACT HEALTH MANAGEMENT SYSTEMS
|
Infusion pump management system for suggesting an adapted course of therapy | ||
Patent #
US 5,643,212 A
Filed 03/07/1994
|
Current Assignee
Hospira Incorporated
|
Original Assignee
Wayne P. Griffin, James E. Coutre, Charles M. Crisler
|
Rapid response occlusion detector for a medication infusion pump | ||
Patent #
US 5,647,853 A
Filed 03/03/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Glucose sensor assembly | ||
Patent #
US 5,660,163 A
Filed 05/18/1995
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Computerized medical diagnostic and treatment advice system | ||
Patent #
US 5,660,176 A
Filed 12/29/1993
|
Current Assignee
Clinical Decision Support LLC
|
Original Assignee
First Opinion Corporation
|
Medication infusion device with blood glucose data input | ||
Patent #
US 5,665,065 A
Filed 05/26/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Soybean peroxidase electrochemical sensor | ||
Patent #
US 5,665,222 A
Filed 10/11/1995
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Infusion pump with an electronically loadable drug library and a user interface for loading the library | ||
Patent #
US 5,681,285 A
Filed 06/19/1996
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
Medicinal fluid pump having multiple stored protocols | ||
Patent #
US 5,685,844 A
Filed 01/06/1995
|
Current Assignee
Hospira Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Flexible patient monitoring system featuring a multiport transmitter | ||
Patent #
US 5,687,734 A
Filed 10/20/1994
|
Current Assignee
Philips Electronics North America Corporation
|
Original Assignee
HP Inc.
|
Ambulatory infusion pump | ||
Patent #
US 5,482,446 A
Filed 03/09/1994
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
Flex circuit connector | ||
Patent #
US 5,482,473 A
Filed 05/09/1994
|
Current Assignee
MINI Med Incorporated
|
Original Assignee
Minimed Inc.
|
Pump simulation apparatus | ||
Patent #
US 5,485,408 A
Filed 07/15/1994
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
SIMS DELTEC INC.
|
Glucose monitoring system | ||
Patent #
US 5,497,772 A
Filed 11/19/1993
|
Current Assignee
MANN ALFRED E. FOUNDATION FOR SCIENTIFIC RESEARCH
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
Analytical system for monitoring a substance to be analyzed in patient-blood | ||
Patent #
US 5,507,288 A
Filed 05/03/1995
|
Current Assignee
Boehringer Mannheim GmbH
|
Original Assignee
Boehringer Mannheim GmbH
|
Biosensor including chemically modified enzymes | ||
Patent #
US 5,543,326 A
Filed 03/04/1994
|
Current Assignee
Ioanis Katakis, Ling Ye, Adam Heller
|
Original Assignee
Ioanis Katakis, Ling Ye, Adam Heller
|
Method for optimally positioning and securing the external unit of a transcutaneous transducer of the skin of a living body | ||
Patent #
US 5,545,191 A
Filed 05/06/1994
|
Current Assignee
Alfred E. Mann Foundation For Scientific Research
|
Original Assignee
Alfred E. Mann Foundation For Scientific Research
|
System for infusion of medicine into the body of a patient | ||
Patent #
US 5,558,640 A
Filed 03/08/1995
|
Current Assignee
Siemens Aktiengesellschaft
|
Original Assignee
Siemens AG
|
Method and apparatus for wireless chemical supplying | ||
Patent #
US 5,569,187 A
Filed 08/16/1994
|
Current Assignee
Texas Instruments Inc.
|
Original Assignee
Texas Instruments Inc.
|
Closed loop infusion pump system with removable glucose sensor | ||
Patent #
US 5,569,186 A
Filed 04/25/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Remotely programmable infusion system | ||
Patent #
US 5,573,506 A
Filed 11/25/1994
|
Current Assignee
Kimberly-Clark Worldwide Incorporated
|
Original Assignee
Block Medical Inc.
|
Ambulatory medication delivery system | ||
Patent #
US 5,582,593 A
Filed 07/21/1994
|
Current Assignee
Barry W. Hultman
|
Original Assignee
Barry W. Hultman
|
Syringe actuation system | ||
Patent #
US 5,584,814 A
Filed 01/26/1995
|
Current Assignee
John F. Schlyer, John H. Schuster
|
Original Assignee
John F. Schlyer, John H. Schuster
|
Transcutaneous sensor insertion set | ||
Patent #
US 5,586,553 A
Filed 02/16/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Transcutaneous sensor insertion set | ||
Patent #
US 5,390,671 A
Filed 03/15/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Method of fabricating thin film sensors | ||
Patent #
US 5,391,250 A
Filed 03/15/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Method of making a thin film electrical component | ||
Patent #
US 5,403,700 A
Filed 01/22/1992
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Techniques to improve the performance of electrochemical sensors | ||
Patent #
US 5,411,647 A
Filed 01/25/1994
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Patient monitoring system | ||
Patent #
US 5,417,222 A
Filed 01/21/1994
|
Current Assignee
Koninklijke Philips N.V.
|
Original Assignee
HP Inc.
|
Programmable portable infusion pump system | ||
Patent #
US 5,429,602 A
Filed 06/10/1994
|
Current Assignee
Jean-Luc Hauser
|
Original Assignee
Jean-Luc Hauser
|
Medical pump driving device | ||
Patent #
US 5,437,634 A
Filed 04/22/1993
|
Current Assignee
Terumo Kabushiki Kaisha
|
Original Assignee
Terumo Kabushiki Kaisha
|
Infusion system having plural fluid input ports and at least one patient output port | ||
Patent #
US 5,464,392 A
Filed 03/07/1994
|
Current Assignee
Hospira Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Ambulatory infusion pump | ||
Patent #
US 5,478,211 A
Filed 03/09/1994
|
Current Assignee
Baxter International Inc.
|
Original Assignee
Baxter International Inc.
|
Mounting clip for a medication infusion pump | ||
Patent #
US 5,472,317 A
Filed 06/03/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Acrylic copolymer membranes for biosensors | ||
Patent #
US 5,284,140 A
Filed 02/11/1992
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Apparatus and method for implantation of sensors | ||
Patent #
US 5,299,571 A
Filed 01/22/1993
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Modular microprocessor-based health monitoring system | ||
Patent #
US 5,307,263 A
Filed 11/17/1992
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
RAYA Systems Incorporated
|
Infusion fluid management system | ||
Patent #
US 5,317,506 A
Filed 05/12/1992
|
Current Assignee
Hospira Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Network for portable patient monitoring devices | ||
Patent #
US 5,319,363 A
Filed 08/20/1992
|
Current Assignee
The General Hospital Corporation
|
Original Assignee
The General Hospital Corporation
|
Hydrophilic polyurethane membranes for electrochemical glucose sensors | ||
Patent #
US 5,322,063 A
Filed 10/04/1991
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
Electrode and method for the detection of hydrogen peroxide | ||
Patent #
US 5,320,725 A
Filed 05/08/1992
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Systems and methods for communicating with ambulatory medical devices such as drug delivery devices | ||
Patent #
US 5,338,157 A
Filed 09/09/1992
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Pharmacia Deltec Inc.
|
Portable medical interactive test selector having plug-in replaceable memory | ||
Patent #
US 5,341,291 A
Filed 03/08/1993
|
Current Assignee
ARCH Development Corporation
|
Original Assignee
ARCH Development Corporation
|
Home medical system and medical apparatus for use therewith | ||
Patent #
US 5,339,821 A
Filed 10/26/1992
|
Current Assignee
Universal Entertainment Corporation
|
Original Assignee
SETA Corporation, Nasa
|
Pacemaker telemetry system | ||
Patent #
US 5,350,411 A
Filed 06/28/1993
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Remote monitoring of high-risk patients using artificial intelligence | ||
Patent #
US 5,357,427 A
Filed 03/15/1993
|
Current Assignee
Hewlett-Packard Development Company L.P.
|
Original Assignee
Digital Equipment Corporation
|
Interferant eliminating biosensor | ||
Patent #
US 5,356,786 A
Filed 12/02/1993
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Systems and methods for operating ambulatory medical devices such as drug delivery devices | ||
Patent #
US 5,368,562 A
Filed 07/30/1993
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Pharmacia Deltec Inc.
|
Process for the continuous and discontinuous administration of insulin to the human body | ||
Patent #
US 5,364,346 A
Filed 03/16/1994
|
Current Assignee
Jurgen Schrezenmeir
|
Original Assignee
Jurgen Schrezenmeir
|
Data transfer system for an infusion pump | ||
Patent #
US 5,376,070 A
Filed 09/29/1992
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Proctective case for a medication infusion pump | ||
Patent #
US 5,370,622 A
Filed 04/28/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
Glucose test data acquisition and management system | ||
Patent #
US 5,371,687 A
Filed 11/20/1992
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Boehringer Mannheim Corporation
|
Medical infusion apparatus | ||
Patent #
US 5,211,626 A
Filed 12/17/1990
|
Current Assignee
PRODUCT INNOVATION HOLDINGS LTD.
|
Original Assignee
PRODUCT INNOVATION HOLDINGS LTD.
|
Diabetes therapy management system, apparatus and method | ||
Patent #
US 5,216,597 A
Filed 05/28/1991
|
Current Assignee
EURUS LLC
|
Original Assignee
DIVA MEDICAL SYSTEMS BV
|
Enzyme electrodes | ||
Patent #
US 5,262,035 A
Filed 08/02/1989
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
E. HELLER AND COMPANY
|
Interferant eliminating biosensors | ||
Patent #
US 5,262,305 A
Filed 09/03/1991
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Portable pump for the administration of a therapeutic | ||
Patent #
US 5,266,013 A
Filed 03/25/1991
|
Current Assignee
Asulab SA
|
Original Assignee
Asulab SA
|
Enzyme electrodes | ||
Patent #
US 5,264,105 A
Filed 03/17/1993
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Enzyme electrodes | ||
Patent #
US 5,264,104 A
Filed 05/08/1992
|
Current Assignee
Therasense Incorporated
|
Original Assignee
E. Heller Company
|
Programmable infusion system | ||
Patent #
US 5,078,683 A
Filed 05/04/1990
|
Current Assignee
Kimberly-Clark Worldwide Incorporated
|
Original Assignee
Block Medical Inc.
|
Infusion pump with dual position syringe locator | ||
Patent #
US 5,080,653 A
Filed 04/16/1990
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Remotely programmable infusion system | ||
Patent #
US 5,100,380 A
Filed 05/16/1989
|
Current Assignee
Hospira Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Medication infusion system having optical motion sensor to detect drive mechanism malfunction | ||
Patent #
US 5,097,122 A
Filed 04/16/1990
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Thin film electrical component | ||
Patent #
US 5,108,819 A
Filed 02/14/1990
|
Current Assignee
Disetronic Licensing Ag
|
Original Assignee
Eli Lilly and Company
|
System for monitoring and controlling blood glucose | ||
Patent #
US 5,101,814 A
Filed 08/11/1989
|
Current Assignee
CB-CARMEL BIOTECHNOLOGY LTD.
|
Original Assignee
Yoram Palti
|
Implantable ambulatory electrocardiogram monitor | ||
Patent #
US 5,113,869 A
Filed 08/21/1990
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Telectronics Pacing Systems Inc
|
An infusion management and pumping system having an alarm handling system | ||
Patent #
US 5,153,827 A
Filed 01/30/1989
|
Current Assignee
Abbott Laboratories Incorporated
|
Original Assignee
OMNI-FLOW INC.
|
Implantable glucose sensor | ||
Patent #
US 5,165,407 A
Filed 04/09/1991
|
Current Assignee
University of Kansas
|
Original Assignee
University of Kansas
|
Diabetes management system and apparatus | ||
Patent #
US 5,019,974 A
Filed 02/22/1990
|
Current Assignee
EURUS LLC
|
Original Assignee
DIVA MEDICAL SYSTEMS BV
|
Infusion pump and drive systems therefor | ||
Patent #
US 5,034,004 A
Filed 10/23/1989
|
Current Assignee
University of Melbourne
|
Original Assignee
University of Melbourne
|
Device for computer-assisted monitoring of the body | ||
Patent #
US 5,050,612 A
Filed 09/12/1989
|
Current Assignee
Kenneth N. Matsumura
|
Original Assignee
Kenneth N. Matsumura
|
Drug infusion system with calculator | ||
Patent #
US 4,898,578 A
Filed 01/26/1988
|
Current Assignee
Baxter Travenol Laboratories Incorporated
|
Original Assignee
Baxter International Inc.
|
Methods of operating enzyme electrode sensors | ||
Patent #
US 4,935,105 A
Filed 10/18/1989
|
Current Assignee
Imperial Chemical Industries PLC
|
Original Assignee
Imperial Chemical Industries PLC
|
Blood glucose monitoring system | ||
Patent #
US 4,953,552 A
Filed 04/21/1989
|
Current Assignee
Arthur P. Demarzo
|
Original Assignee
Arthur P. Demarzo
|
Personal health monitor | ||
Patent #
US 4,803,625 A
Filed 06/30/1986
|
Current Assignee
Instromedix Inc.
|
Original Assignee
BUDDY SYSTEMS INC.
|
Interactive programming and diagnostic system for use with implantable pacemaker | ||
Patent #
US 4,809,697 A
Filed 10/14/1987
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
SIEMENS-PACESETTER INC.
|
System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof | ||
Patent #
US 4,826,810 A
Filed 03/19/1987
|
Current Assignee
Thomas Tarnay
|
Original Assignee
Thomas Tarnay
|
Cassette for programable multiple input infusion system | ||
Patent #
US 4,865,584 A
Filed 04/16/1987
|
Current Assignee
Hospira Incorporated
|
Original Assignee
OMNI-FLOW INC.
|
Implantable medication infusion system | ||
Patent #
US 4,871,351 A
Filed 08/26/1987
|
Current Assignee
Vladimir Feingold
|
Original Assignee
Vladimir Feingold
|
Programmable control means for providing safe and controlled medication infusion | ||
Patent #
US 4,731,051 A
Filed 02/15/1983
|
Current Assignee
JOHNS HOPKINS UNIVERSITY THE BALTIMORE A CORP. OF MD
|
Original Assignee
Johns Hopkins University
|
Patient-operated glucose monitor and diabetes management system | ||
Patent #
US 4,731,726 A
Filed 05/19/1986
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
HealthWare Corporation
|
Transparent multi-oxygen sensor array and method of using same | ||
Patent #
US 4,781,798 A
Filed 05/08/1987
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Electrochemical cell sensor for continuous short-term use in tissues and blood | ||
Patent #
US 4,671,288 A
Filed 06/13/1985
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Solenoid drive apparatus for an external infusion pump | ||
Patent #
US 4,678,408 A
Filed 09/24/1985
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
External infusion pump apparatus | ||
Patent #
US 4,685,903 A
Filed 01/06/1984
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Infusion system having plural fluid input ports and at least one patient output port | ||
Patent #
US 4,696,671 A
Filed 06/11/1986
|
Current Assignee
Hospira Incorporated
|
Original Assignee
OMNI-FLOW INC.
|
Complete glucose monitoring system with an implantable, telemetered sensor module | ||
Patent #
US 4,703,756 A
Filed 05/06/1986
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Solenoid drive apparatus for an external infusion pump | ||
Patent #
US 4,562,751 A
Filed 01/06/1984
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Plural module medication delivery system | ||
Patent #
US 4,494,950 A
Filed 01/19/1982
|
Current Assignee
Johns Hopkins University
|
Original Assignee
Johns Hopkins University
|
Ambulatory infusion pump having programmable parameters | ||
Patent #
US 4,529,401 A
Filed 01/11/1982
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Dual-antenna transceiver | ||
Patent #
US 4,542,532 A
Filed 03/09/1984
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Acquisition circuit for cardiac pacer | ||
Patent #
US 4,550,731 A
Filed 03/07/1984
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Cordis Corporation
|
Device for the pre-programmable infusion of liquids | ||
Patent #
US 4,559,037 A
Filed 01/20/1984
|
Current Assignee
Siemens AG
|
Original Assignee
Siemens AG
|
Mixtures of polymers for medical use | ||
Patent #
US 4,433,072 A
Filed 04/29/1983
|
Current Assignee
HOSPAL-SODIP S.A.
|
Original Assignee
HOSPAL-SODIP S.A.
|
Programmable implantable infusate pump | ||
Patent #
US 4,443,218 A
Filed 09/09/1982
|
Current Assignee
Flowonix Medical Inc.
|
Original Assignee
Infusaid Corporation
|
Apparatus for infusing medication | ||
Patent #
US 4,469,481 A
Filed 06/16/1982
|
Current Assignee
Terumo Kabushiki Kaisha As Terumo Corporation
|
Original Assignee
Terumo Corporation
|
Apparatus for improving blood sugar control in diabetics | ||
Patent #
US 4,475,901 A
Filed 11/06/1981
|
Current Assignee
Commonwealth Scientific and Industrial Research Organization, GARVAN RESEARCH DEVELOPMENT LIMITED THE NEW SOUTH WALES 384 VICTORIA STREET DARLINGHURST NEW SOUTH WALES 2010 AUSTRALIA
|
Original Assignee
THE GARVAN RESEARCH DEVELOPMENT LTD., Commonwealth of Australia
|
Implantable, programmable medication infusion system | ||
Patent #
US 4,373,527 A
Filed 04/27/1979
|
Current Assignee
Johns Hopkins University
|
Original Assignee
Johns Hopkins University
|
Infusion pump controller | ||
Patent #
US 4,392,849 A
Filed 07/27/1981
|
Current Assignee
Cleveland Clinic Foundation
|
Original Assignee
Cleveland Clinic Foundation
|
Device for the infusion of fluids into the human or animal body | ||
Patent #
US 4,395,259 A
Filed 09/14/1981
|
Current Assignee
Siemens AG
|
Original Assignee
Siemens AG
|
Device for the pre-programmable infusion of liquids | ||
Patent #
US 4,270,532 A
Filed 12/13/1978
|
Current Assignee
Siemens AG
|
Original Assignee
Siemens AG
|
Device for the pre-programmable infusion of liquids | ||
Patent #
US 4,282,872 A
Filed 12/13/1978
|
Current Assignee
Siemens AG
|
Original Assignee
Siemens AG
|
METHOD AND APPARATUS FOR INJECTING FLUID INTO THE VASCULAR SYSTEM | ||
Patent #
US 3,631,847 A
Filed 03/25/1969
|
Current Assignee
James C. Hobbs II
|
Original Assignee
James C. Hobbs II
|
16 Claims
-
1. A method of infusing a fluid into a body of a user comprising:
-
operating a physiological monitoring device carried on the exterior of the body of the user, to perform the operations of; measuring an output signal produced by a sensor, the output signal being a function of a concentration of an analyte in the user; determining a first amount of time that has elapsed since the sensor provided the output signal; determining whether the first amount of time exceeds a predetermined amount of time; and
, if the first amount of time does not exceed the predetermined amount of time,calculating an amount of the fluid to be infused into the user'"'"'s body based upon the output signal; and transmitting a first set of data with a first communication circuit enclosed within a first housing of the physiological monitoring device, the first set of data being indicative of the amount of the fluid to be infused, the first set of data further including an identifier associated with the amount of fluid to be infused; wherein the amount of fluid to be infused into the user'"'"'s body based upon the output signal is not calculated if the first amount of time exceeds the predetermined amount of time; and operating a medication infusion device carried on the exterior of the body of the user, to perform the operations of; receiving the first set of data with a second communication circuit enclosed within a second housing of the medication infusion device carried on the exterior of the body of the user; verifying the identifier to ensure the amount of fluid to be infused has not already been administered; and activating a drive mechanism to infuse the fluid in accordance with the first set of data. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
1 Specification
This application claims priority from U.S. Provisional Application No. 60/398,213, filed Jul. 24, 2002. This application is a continuation application of pending U.S. application Ser. No. 10/624,177, filed Jul. 22, 2003, which is incorporated by reference in its entirety.
This invention relates generally to improvements in medical devices, such as patient physiological monitoring systems and medication infusion systems that are used for controlled delivery of medication to a user. More specifically, this invention relates to improved methods and apparatuses for calculating and communicating the quantity or bolus of medication that is to be delivered to the user.
People with Type 1 diabetes and some with Type 2 diabetes use insulin to control their blood glucose (BG) level. Typically, if a person'"'"'s BG level is too high, he or she can inject a “bolus” (dose) of insulin to lower his/her BG level to a desired target level. Furthermore, he or she may inject a bolus of insulin in anticipation of ingesting carbohydrates, thus heading off a sharp rise in BG level.
Various calculations can be used to determine the amount of insulin to inject, and bolus estimation software is available for performing such calculations. These software programs can be used on an electronic computing device, such as a computer, the Internet, a personal digital assistant (PDA), or an insulin delivery device. Insulin delivery devices include infusion pumps, injection pens, and IV meters.
Some bolus estimation software takes into account an individual'"'"'s current BG level. Presently, blood glucose can be measured using devices such as a test strip meter, a continuous glucose measurement system, a hospital hemocue, or an automated intermittent blood glucose measurement system. BG measurement devices use various methods, such as a sample of blood, a sensor in contact with a bodily fluid, an optical sensor, an enzymatic sensor, or a fluorescent sensor.
When the BG measurement device has generated a measurement, it is displayed on the device. Then the user may visually read the BG measurement and physically enter it into an electronic computing device to calculate a bolus estimate. Finally, once the bolus estimate is calculated, the user can inject the insulin bolus, or can program an insulin delivery device to deliver the bolus into his/her body.
Unfortunately, this process can be cumbersome and subject to transcribing errors—for example, the user may not accurately enter the BG measurement that is displayed on the BG measurement device into the electronic computing device. Thus if the BG measurement is not entered correctly, the bolus estimate may not be accurate. Furthermore, once the bolus estimation calculation is complete, the user may not accurately enter the bolus amount into a programmable infusion device, or the user may read the bolus amount incorrectly and inject the wrong amount of medication.
A physiological monitoring device that conducts a bolus estimation calculation is provided. In one aspect, the monitoring device communicates a bolus amount resulting from the bolus estimation calculation to a medication infusion device, which delivers a bolus of medication to a user based on the communication from the monitoring device. The medication infusion device delivers the medication automatically after receiving the communication from the monitoring device.
In another aspect, the monitoring device comprises a processor and a sensor coupled to the processor and adapted to provide an output signal as a function of a concentration of an analyte in the user. A communication circuit is coupled to the processor. The processor is adapted to calculate an amount of the medication or fluid to be infused into the user'"'"'s body based upon the sensor output signal, and to cause the monitoring device communication circuit to transmit a set of data indicative of the amount of the fluid to be infused.
An indicator is coupled to the monitoring device processor and adapted to provide a notification of the following events: the measuring of the output signal produced by the sensor, the calculating of the amount of the fluid, and the transmitting of the set of data by the first communication circuit.
The medication infusion device comprises a processor and a drive mechanism coupled to the processor and adapted to infuse the fluid into the user'"'"'s body. A communication circuit is coupled to the processor and adapted to receive the set of data from the monitoring device communication circuit. The processor is adapted to cause the drive mechanism to automatically infuse the fluid into the user in accordance with the set of data.
In another aspect, the monitoring device communication circuit is a transmitter or a transceiver, and the infusion device communication circuit is a receiver or a transceiver.
In an alternative embodiment, the monitoring device further comprises a user input device for inputting commands. The monitoring device communication circuit transmits the first set of data in response to a command from the input device.
In another aspect, the monitoring device processor is further adapted to determine a first amount of time that has elapsed since the sensor provided the output signal and to cause the monitoring device communication circuit to transmit the first set of data if the first amount of time does not exceed a predetermined amount of time.
In yet another embodiment, the monitoring device further comprises an indicator coupled to the monitoring device processor and adapted to provide a display of the amount of the fluid and a user input device for inputting commands. The monitoring device processor is further adapted to cause the monitoring device communication circuit to transmit the first set of data in response to a first command from the input device.
In another aspect, the infusion device further comprises a user input device for inputting commands and an indicator coupled to the infusion device processor and adapted to provide a display of the amount of the fluid. An infusion device memory is coupled to the infusion device processor and adapted to store at least two fluid infusion parameters. The infusion device processor is further adapted to retrieve one of the fluid infusion parameters from the memory in response to a command from the input device associated with a selection by the user. The infusion device processor further causes the drive mechanism to infuse the fluid into the user'"'"'s body in accordance with the first or second fluid infusion parameter.
In an alternative embodiment, the monitoring device processor is further adapted to cause the monitoring device communication circuit to transmit a first command repeatedly for a plurality of transmissions and the infusion device communication circuit is further adapted to receive the first command. The infusion device processor is further adapted to cause power to the infusion device communication circuit to be cycled whereby the power is removed from the infusion device communication circuit for a first time period and is restored to the infusion device communication circuit for a second time period. The infusion device processor causes the power to the infusion device communication circuit to be restored and the power cycling to be discontinued if the first command has been received.
In yet another embodiment, the monitoring device sensor is coupled to the monitoring device processor and adapted to provide first and second output signals as a function of first and second quantities of an analyte in the user. The monitoring device processor is adapted to calculate a first amount of the fluid to be infused into the user'"'"'s body based upon the first output signal and generate a first code associated with the first amount of the fluid. The processor then causes the monitoring device telemetry circuit to transmit a first plurality of transmissions wherein each of the first plurality of transmissions is comprised of a first set of data and the first code, the first set of data being indicative of the first amount of the fluid.
The monitoring device processor then calculates a second amount of the fluid to be infused into the user'"'"'s body based upon the second output signal and generates a second code associated with the second amount of the fluid. The processor next causes the monitoring device telemetry circuit to transmit a second plurality of transmissions wherein each of said second plurality of transmissions is comprised of a second set of data and the second code, the second set of data being indicative of the second amount of the fluid.
The infusion device telemetry circuit is adapted to receive the first and second plurality of transmissions from the monitoring device telemetry circuit. The infusion device processor is adapted to store a first received code, said first received code being the first code or the second code as received from one of the first or second plurality of transmissions. The processor then compares a second received code with the first received code, where the second received code is another of the first or second codes as received from another of the first or second plurality of transmissions. The processor then causes the drive mechanism to apply pressure to the fluid in accordance with the second set of data if the second received code does not equal the first received code.
In one aspect, the first code is generated by incrementing a counter to provide a first counter value and the second code is generated by incrementing the counter to provide a second counter value. In another aspect, the first code corresponds to a first date and time and the second code corresponds to a second date and time.
There are additional aspects to the present inventions. It should therefore be understood that the preceding is merely a brief summary of some embodiments and aspects of the present inventions. Additional embodiments and aspects of the present inventions are referenced below. It should further be understood that numerous changes to the disclosed embodiments can be made without departing from the spirit or scope of the inventions. The preceding summary therefore is not meant to limit the scope of the inventions. Rather, the scope of the inventions is to be determined by appended claims and their equivalents.
In the following description, reference is made to the accompanying drawings which form a part hereof and which illustrate several embodiments of the present invention. It is understood that other embodiments may be used and structural and operational changes may be made without departing from the scope of the present invention.
A physiological monitoring device that conducts a bolus estimation calculation is provided. In one aspect, the monitoring device communicates a bolus amount resulting from the bolus estimation calculation to a medication infusion device, which then delivers a bolus of medication to a user based on the communication from the monitoring device. The monitoring device may also be used to control other functions of the medication infusion device based on communications from the monitoring device.
Referring to
In particular embodiments, the physiological monitoring device is the BG meter 10 which includes a test strip receptacle or port 11 for receiving and analyzing the test strip 12 with the sample 14 of the user'"'"'s blood to obtain a BG measurement. In alternative embodiments, the monitoring device may be a continuous glucose measurement system, a hospital hemocue, or an automated intermittent blood glucose measurement system. For example, the monitoring device may generally be of the type or include features disclosed in U.S. Pat. No. 6,558,320, U.S. Patent Application Publication No. 20020002326, published on Jan. 3, 2003, and U.S. patent application Ser. No. 09/377,472 filed Aug. 19, 1999 and entitled “Telemetered Characteristic Monitor System and Method of Using the Same,” and Ser. No. 09/334,996 filed Jun. 17, 1999 and entitled “Characteristic Monitor with a Characteristic Meter and Method of Using the Same,” which are herein incorporated by reference. Moreover, the monitoring device may use other methods or sensors for measuring the user'"'"'s BG level, such as a sensor in contact with a body fluid, an optical sensor, an enzymatic sensor, a fluorescent sensor, or a blood sample placed in a receptacle. Some monitoring devices are adapted to be carried by a user during his or her daily activities, and thus, may be implanted within the body of the user, or may be external to the user'"'"'s body and hand-held, or held in a clothing pocket or attached to the body or clothing by straps, adhesives, fasteners, etc.
In further alternative embodiments, the monitoring device may use samples from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, or sweat. Other physiological determining or measuring devices may be used to determine or measure the concentrations or quantities of other characteristics, analytes, or agents in the user, such as hormones, cholesterol, medication concentrations, viral loads (e.g., HIV), lactose, oxygen, pH, heart rate, respiratory rate, etc. which may be used in a bolus estimation algorithm or may be used to identify an alarm condition or record an event.
Referring again to
In the illustrated embodiment, the test strip port 11 and RF transmitter 15 are coupled to a processor 17, which executes programs (including the bolus estimator 64) and controls the BG meter 10. The processor 17 is also connected to a memory 30 for storing programs, history data, user defined information and parameters. The BG meter 10 also includes an indicator or display 16 for providing notifications to the user of the BG measurement, bolus amount information, and messages, such as status, alarms or error messages. In particular embodiments, the display 16 includes a backlight for reading the display 16 in the dark.
The BG meter 10 includes user input devices comprising one or more housing buttons 18 and 20 for control of the meter 10, such as turning it on or off, reviewing previous BG measurements or bolus amounts, transmitting bolus data to the infusion pump 50, and turning off the transmitter 15 (or transceiver 19 (shown in
The BG meter 10 further includes an additional user input device comprising a keypad 28 with one or more keypad buttons 22, 24, and 26 that are dedicated to remotely controlling the infusion pump 50, for example, via the RF transmitter 15 (or RF transceiver 19 (as shown in
In alternative embodiments, other quantities and arrangements of buttons may be included on the meter 10, and the buttons may be labeled other than as illustrated in
In addition to transmitting the bolus amount data to the infusion pump 50, the BG meter 10 also stores the BG measurement and bolus data in the memory 30 of the BG meter 10 for subsequent analysis and review. A history of alarms or error messages generated by the BG meter 10, as well as remote control commands sent to or information received from the infusion pump 50, may also be stored in the memory 30. Further, the user may periodically cause the BG meter 10 to download the stored data through a communication circuit (such as the RF transmitter 15 (or RF transceiver 19 (as shown in
Referring now to
In alternative embodiments, other devices may be used for delivery or infusion of fluid into a user'"'"'s body, such as for example, an implantable insulin infusion pump or a system that uses a combination of implantable and external components, an injection pen, an IV meter, etc.
Referring still to
The RF communication system 60 communicates with a processor 64 contained in a housing 52 of the infusion pump 50. The processor 64 is used to execute programs and control the infusion pump 50, and is connected to an internal memory device 66 that stores programs, history data, user defined information and parameters. The memory device 66 is a ROM and DRAM, but alternatively, the memory device 66 may include other memory storage devices, such as RAM, EPROM, dynamic storage such as flash memory, energy efficient hard-drive, etc.
The infusion pump 50 is preferably programmed through a user input device comprising a keypad 58 on the housing 52, or alternatively, by commands received from an RF programmer (not shown) through the RF communication system 60. The infusion pump 50 may also be programmed by commands that are input using the keypad 28 on the BG meter 10 and received from the BG meter 10, for example, through the RF communication system 60, as will be described below. Feedback by the infusion pump 50 on status or programming changes is shown on a display 68, is provided tactilely with a vibration alarm 78 or audibly through a speaker 70 or other sound generation device. The infusion pump 50 may also provide the user with either an audible alarm or a vibration alarm for notification of a low medication reservoir condition or low battery charge. Alarms may start out at a low decibel or vibration level and escalate until acknowledged by the user. In alternative embodiments, the keypad 58 may include other quantities and arrangements of keys than those illustrated in
The processor 64 is also coupled to a drive mechanism 72 that is connected to a fluid reservoir 74 containing fluid. The processor 64 causes the drive mechanism 72 to deliver the fluid through an outlet 76 in the reservoir 74 and housing 52, and then into the user'"'"'s body through the tubing 54 and the infusion set 56.
In particular embodiments, one-way communication is provided from the BG meter 10 to the infusion pump 50. The BG meter 10 includes the RF transmitter 15 (shown in
The infusion pump 50 provides several programming options, including remote and on-device programming. The infusion pump 50 also can be configured through a communication circuit, such as a cable or communication station, using a computer. Additionally, the infusion pump 50 allows the user to download information in the memory 66 through the communication circuit directly to a computer, or alternatively, over the Internet to a remote server for storage. Further description of a communication station of this general type may be found in U.S. Pat. No. 5,376,070, which is incorporated herein by reference. The user or a caregiver (e.g., the user'"'"'s parent, health care professional, educator) can evaluate the user'"'"'s therapy by accessing the historical BG measurements or bolus data downloaded from the BG meter 10 and insulin delivery information downloaded from the pump 50.
Information may also be downloaded from the infusion pump 50 through the RF communication system 60. Referring to
In other embodiments, the connector 32 may be inserted into the test strip port 11′ of the BG meter 10′ to provide a wired connection to a USB, serial, or other port of the computer 34, as shown in
Alternatively, information may be transmitted from the RF transceiver 81 in the infusion pump 50 to the RF transceiver 36 in the BG meter 10″, as shown in
As previously stated, the BG meter 10 analyzes the blood sample 14 on the test strip 12 to calculate a BG measurement. The BG meter 10 next calculates a bolus amount and communicates the bolus amount to the infusion pump 50. The pump 50 then delivers a bolus of the medication into the user based on the bolus amount data received from the BG meter 10. In particular embodiments, the BG meter 10 automatically communicates the bolus amount data to the pump 50 once the BG meter 10 calculates the bolus amount. Alternatively, the BG meter 10 communicates the bolus amount to the pump 50 upon removal of the test strip 12 from the BG meter 10, or in response to an action by the user.
The BG meter 10 provides notification to the user of several events, including when it is analyzing a blood sample, calculating a bolus amount, and communicating with the pump 50. In particular embodiments, the notification is provided as a status on the display 16. In alternative embodiments, the status is communicated to the user in other ways, such as using one or more light emitting diodes, a vibrator or other tactile device, or one or more audible tones (generated by a speaker, a piezoelectric sound generator or other sound generating device). However, when the BG meter 10 provides continuous or automatic BG measurements, the user is not constantly notified of the status of the calculations and transmissions.
Optionally, the user can direct the BG meter 10 to calculate a bolus estimate amount and/or provide bolus data to the infusion pump 50. User input devices and methods for inputting commands to cause a bolus estimation calculation to be conducted and to transmit bolus data to the infusion pump 50 include: pressing a button, activating a user interface, touching a screen, selecting a menu item, and entering information about a meal such as carbohydrates to be ingested. The BG meter 10 may also re-transmit the bolus amount data to the pump 50 in response to a user action such as pressing a button, selecting a menu item, holding down a button, aligning the BG meter 10 and infusion pump 50, etc. Alternatively, the BG meter 10 may be notified by the infusion pump 50 to re-transmit the bolus amount data.
In particular embodiments, the BG meter 10 increments a counter each time a new bolus amount is calculated and communicated to the pump 50. If a previously calculated and transmitted bolus amount is re-transmitted, then the BG meter 10 does not increment the counter. Each transmission from the BG meter 10 to the infusion pump 50 includes the bolus amount and the counter value. When the infusion pump 50 receives the transmission from the BG meter 10, the pump compares the counter in the new transmission to the counter in a previous transmission. If the counter has not incremented, the infusion pump 50 will ignore the new transmission since it is a duplicate of a previously-received communication. Thus, the infusion pump 50 will activate an insulin delivery only once for each calculated bolus amount.
In alternative embodiments, the BG meter 10 generates a unique code associated with each bolus amount that is communicated to the pump 50. Each transmission from the BG meter 10 to the pump 50 includes the bolus amount and the unique code. The infusion pump 50 stores each code received and ignores any later transmission containing a code that was previously received. In one aspect, the BG meter 10 includes a clock circuit adapted to provide a date and time that may be used to generate the code, or alternatively, the date and time may be used as a counter.
In some embodiments, the BG meter 10 keeps track of the elapsed time between the point when a BG measurement is obtained and when a bolus amount is communicated to the infusion pump 50. The infusion pump 50 includes a clock circuit adapted to provide a date and time, and thus the pump 50 only delivers medication in a bolus amount received from the BG meter 10 if the BG measurement used in the bolus estimation calculation is sufficiently recent in time. Bolus estimations can be at least partially dependent on the difference between the user'"'"'s present blood glucose level and a desired target blood glucose level. Since a user'"'"'s BG level varies over time, using a bolus estimation based on an old BG measurement might be inappropriate for the user.
A bolus estimation is expired (and will not be used for delivering medication to a user) when the BG measurement is too old to be considered representative of the user'"'"'s present BG level. Thus the BG meter 10 will not transmit a bolus amount to the infusion pump 50 if 10 minutes or more have elapsed since the BG measurement was taken. Alternative shorter or longer time delays may be used, however, such as 7 minutes, 5 minutes, 4 minutes, 3 minutes, or 2 minutes, etc., as well as 12 minutes, 15 minutes, 20 minutes, 30 minutes, 1 hour, 1½ hour, 2 hours, 2½ hours, 3 hours, 3½ hours, 4 hours, etc. Alternatively, the time required for a BG measurement to expire may be set by the user, a caregiver, a physician, a parent, a guardian, etc. For example, a child'"'"'s BG level may change more quickly than that of a heavy adult, so the BG meter 10 may be programmed so that BG measurements older than 5 minutes cannot be transmitted to another device. On the other hand, an adult might program the BG meter 10 so that BG measurements expire after 12 minutes.
Alternatively, the infusion pump 50 is programmed to not use a bolus amount if the BG measurement used in the bolus estimation calculation has expired. The infusion pump 50 keeps track of the elapsed time between the point when a new bolus amount is received from the BG meter 10 and when the bolus amount is used to activate an insulin delivery. For example, the infusion pump 50 may be provided the age of the bolus amount it receives. In other words, the elapsed time between when a BG measurement is collected and when the bolus amount is communicated to the infusion pump 50 is transmitted along with each set of bolus data. The pump then can calculate the current age of the bolus amount by adding the age of the bolus amount at the time it was communicated to the time that has passed since the bolus amount was received. Thus, since the infusion pump 50 knows the age of the bolus amount, the infusion pump 50 can reject bolus amounts that are expired. Alternatively, the infusion pump 50 notifies the user if a bolus amount has been received but is expired, before the bolus amount is used to activate a medication delivery. The user may then choose to suspend or activate the bolus delivery.
In particular embodiments, the infusion pump processor 64 causes the drive mechanism 72 to deliver or infuse the fluid into the body of the user according to fluid infusion parameters. For example, the pump can deliver the medication in virtually a single dose, i.e., a “normal bolus.” Several minutes may be required to deliver the entire bolus amount depending on other fluid infusion parameters, such as the present basal rate that medication is being delivered, the size of the bolus amount, the delivery location on or in the body, and the maximum rate that the infusion pump 50 can deliver the medication, etc.
The user alternatively may program a bolus type other than a normal bolus. Other delivery profiles or bolus types can include a SQUARE WAVE™ bolus and a DUAL WAVE™ bolus. When a SQUARE WAVE™ bolus is used, the delivery of the bolus is spread at a constant rate over a time period. When a DUAL WAVE™ bolus is used, the user specifies a portion of the bolus amount to be delivered as a normal bolus, and the remaining portion to be delivered as a SQUARE WAVE™ bolus. Other bolus types or profiles can also be used to deliver the bolus amount.
Preferably, the infusion pump 50 automatically activates an insulin delivery almost immediately upon receiving a bolus amount communicated from the BG meter 10, assuming the bolus amount has not expired. Alternatively, the bolus amount can be approved by the user before it is used. The bolus amount is displayed, and the user responds by pressing a button, selecting a menu item, touching a screen, etc., before the bolus amount is used for medication delivery. For example, the bolus amount may be displayed on the display 16 of the BG meter 10 and approved by the user before it is transmitted to the infusion pump 50. Alternatively, the bolus amount may be displayed on the display 68 of the infusion pump 50 and approved by the user before the medication is delivered. Additionally, the user may indicate the bolus type before the bolus is delivered. For example, the user may employ the user input devices on the BG meter 10 to indicate the bolus type and any associated parameters (such as the bolus amount, the bolus delivery duration period, the portion of the bolus amount that is to be delivered immediately, the portion of the bolus amount that is to be delivered over the extended bolus delivery duration period, etc.) along with other parameters that are transmitted to the infusion pump 50 when a bolus amount is to be delivered. Alternatively, the user may use the infusion pump 50 to indicate the bolus type and any associated parameters. The bolus amount may be sent from the BG meter 10 to the infusion pump 50 automatically, whereupon the user input device on the pump 50 may be used to select a bolus type before the bolus is delivered. Additionally, the user can specify a default bolus type.
In some embodiments, the BG meter 10 transmits a bolus amount to the infusion pump 50 using radio frequency (RF) communication. Alternatively, other communication circuits are used, such as infrared (IR), wired, ultrasonic, sonic, optical, etc. Transmissions between the BG meter 10 and the infusion pump 50 may contain unique identifying information associated with the identity of the BG meter 10 and/or the infusion pump 50, such as the BG meter'"'"'s and/or the infusion pump'"'"'s serial number, identification number, a password, a code, etc. The identification information may be used to discern between communications that are intended for the respective device (i.e., the BG meter 10 or the pump 50), and those that are not. Alternative identification information or codes can include a password, a bit sequence, a special frequency, timing between communications, etc.
Preferably, the communication system in the BG meter 10 may be deactivated either automatically or by the user, whereupon the meter will not attempt to communicate with other devices. Thus when a new BG measurement is available, the BG meter 10 will not communicate a bolus amount to another device. For example, the RF transmitter 15 (
Additionally, the BG meter 10 can be programmed to reactivate the communication system after a pre-set duration. When the user deactivates the BG meter'"'"'s communication system, the user is prompted to enter a duration of time for the communication system to remain deactivated. The communication system will automatically become active at the end of the time period. Alternatively, the user may specify a time of day for the communication system to become active. The user is alerted to review any bolus amounts that were generated while the communication system was deactivated. Then the user can request that they be sent to the infusion pump 50 if desired.
In accordance with one embodiment, two-way communication is used between the BG meter 10 and the infusion pump 50. The infusion pump 50 sends an acknowledge (ACK) message to the BG meter 10 when it receives a transmission. In particular embodiments, the BG meter 10 will not re-transmit (even if requested by the user) if the BG meter 10 has received an ACK from the infusion pump 50. Alternatively, the infusion pump 50 echoes the bolus amount back to the BG meter 10 and waits for a confirmation from the BG meter 10 before delivering the bolus amount. The user is alerted when communication between the BG meter 10 and infusion pump 50 is activated but not functioning properly.
The infusion pump 50 preferably uses power cycling to periodically supply power to its communication system 60. The power cycle is the time period that the communication system 60 is off plus the time period that the communication system is on. In some embodiments, the power cycle is 8 seconds in length. Alternatively, shorter or longer power cycles may be used, such as 4 seconds, 2 seconds, or 1 second, etc., as well as 12 seconds, 15 seconds or 20 seconds, etc.
Additionally, the time period that the communication system 60 is on during each power cycle is preferably 48 milliseconds (ms). Alternatively, the period that the communication system is on during each power cycle can be greater or less than 48 ms, depending on the length of the message to be received, the communication frequency, the speed of the communication system electronics, etc. The BG meter 10 sends repeated signals to the infusion pump 50 for a period longer than the power cycle. Each signal sent from the BG meter 10 to the infusion pump 50 includes a command. The command is preferably short enough to be captured during the on-time of the infusion pump'"'"'s 50 communication system 60. In accordance with one embodiment, the command is short enough to be captured twice during the infusion pump'"'"'s 50 communication system 60 on-time.
The time that the infusion pump'"'"'s 50 communication system 60 must be on to capture the command from the BG meter 10 is short compared to the power cycle, or alternatively is short compared to a string of information. When the infusion pump 50 receives the command, the pump 50 stops power cycling its communication system 60 and turns the system 60 on continuously. Thus short commands may be used to activate the infusion pump'"'"'s 50 communication system 60 so that one or more longer strings of information may be received by the pump 50.
The infusion pump 50 prepares to receive a string of information that is longer than a command and includes a bolus amount. The string of information may further include an elapsed time since the BG measurement was taken, a bolus type, bolus parameters, a counter, a unique identification code, a date, a time, a serial number, and the time elapsed since the bolus amount was calculated, etc.
The BG meter 10 may transmit a date and time to the infusion pump 50 so that the pump 50 can determine the difference between the BG meter 10 date and time and the pump 50 date and time. Moreover, the pump 50 can reset its clock to correspond to the BG meter 10 clock. Alternatively, the BG meter 10 can use the infusion pump 50 date and time to reset the BG meter 10 clock. In particular embodiments, when the pump 50 acknowledges receipt of information from the BG meter 10, the pump 50 will communicate its current time and date to the meter 10. The meter 10 then resets its clock, if necessary, to correspond to the pump'"'"'s clock.
The infusion pump 50 preferably returns to power cycling the communication system 60 after information has been received from the BG meter 10. For example, power cycling may be restored after the pump 50 receives a complete signal containing a bolus amount from the BG meter 10. Alternatively, the infusion pump 50 returns to power cycling at a predetermined period after the signal from the BG meter 10 has stopped, or after the commencement of a signal from the BG meter 10.
In alternative embodiments there is no longer string of information that follows a command. Rather, the command itself includes all of the information to be sent to the pump, such as the bolus amount, the bolus type and/or a time parameter, serial number, BG meter counter, etc. Thus the pump does not change from its power cycling routine.
The BG meter 10 is preferably used to control one or more functions of the infusion pump 50. These functions include: bolus delivery (bolus amount, start time, bolus type, duration, maximum bolus amount limit, etc.), basal delivery (profiles, delivery rates, time of day when rates change, maximum basal rate limit, etc.), alarms, user interfaces (turning on or off sound generating devices, vibrator, display, or light, etc.), selection of devices that can communicate with the infusion pump 50, lock-out controls, reservoir seating, reservoir priming, and data download.
Alternative embodiments of a BG meter 10 include one or more indicators and user input devices, such as audible alarms, vibrators, displays (liquid crystal display (LCD), light emitting diodes (LEDs), touch screen, etc.), sound generation devices, keypads, keyboards, buttons, and voice activated controls, etc. In addition to the pump 50, the BG meter 10 can communicate with other devices, such as a computer, PDA, telephone, central server, Internet hardware device, relay, remote alarm or notification device, and a remote controller, etc. The BG meter 10 uses one or more communication circuits or methods to communicate with these other devices, such as RF, infrared (IR), bluetooth, optical, sound, ultrasonic, and wired, etc.
The infusion pump 50 indicates its present function or activity, so that a user can monitor the pump'"'"'s reaction to commands that it has received, for example, from the BG meter 10. Also, the user may override commands that the infusion pump 50 has received from another device. Alternatively, the infusion pump 50 only communicates with a user through another device, such as via the BG meter 10. Examples of functions/activities indicated to the user include: the delivery of a certain basal profile, the completion of delivery to the user of a certain portion of a bolus, the time period remaining for completing a bolus delivery, the suspension of pump 50 operations, the priming or seating of the pump 50, etc. In one embodiment, the infusion pump 50 communicates to the BG meter 10 the pump status or alarms, such as a fluid path occlusion, an electrostatic discharge alarm, a low battery power level, a low reservoir level, etc.
The user accesses and implements commands using the BG meter 10 through a menu structure shown on the display 16 and navigated by the keypad 28. Alternatively, input devices or other methods are used such as pressing dedicated keys, scribing a command on a screen, touching a touch screen, voice activated commands, etc. Each keystroke on the BG meter 10 is communicated to the infusion pump 50. Alternatively, the BG meter 10 only communicates actionable commands to the infusion pump 50. Thus, the user may press many keystrokes on the BG meter 10 before the BG meter 10 transmits to the pump 50.
For example, the BG meter 10 does not communicate to the infusion pump 50 until the user has stopped pressing keys that might influence the infusion pump 50 function. Thus for example, the user might conduct a programming session on the BG meter 10 to implement a new basal delivery pattern, enter a new serial number of a new device that the infusion pump 50 should respond to, and program a bolus amount. The BG meter 10 would not initiate a transmission to the infusion pump 50 until the user has completed the programming session.
The BG meter 10 identifies the end of a programming session when the user inputs a completion command indicating that the session is complete or commanding the BG meter 10 to initiate the transmission. Alternatively, the BG meter 10 communicates at the end of each actionable command. Alternatively still, the BG meter 10 communicates to the infusion pump 50 whenever the user returns to the main menu, or the BG meter 10 waits a specified delay period after the last keystroke to determine that the user has completed the programming session. The specified delay period may be programmable, or may be a preset period such as 10 seconds, 15 seconds, 30 seconds, 1 minute, etc. The BG meter 10 nevertheless will communicate some commands immediately, such as for example, a suspend command (to stop medication delivery), responses to alarms, or starting a new bolus delivery.
In an alternative embodiment, the meter has a review feature so that the user may scroll through programming steps that are about to be sent to the pump. The user may choose to modify the commands or accept the commands before the meter initiates a transmission to the pump.
As described above, the infusion pump 50 communicates with various external devices, such as the BG meter 10, using RF communication. Additionally, the infusion pump 50 uses power cycling to periodically supply power to its communication system 60. Referring to
The RF receiver 80 or RF transceiver 81 receives and demodulates RF signals, extracts a data packet from the RF signal, and passes the data packet to the RF PIC 82. The RF PIC 82 accepts and decodes the data packet and checks for format. If the format of the data packet is valid, the RF PIC 82 sends an interrupt signal to the ASIC 84. When the ASIC 84 receives the interrupt signal from the RF PIC 82, the ASIC 84 sends an interrupt to the processor 64, triggering the processor 64 to notify the RF PIC 82 to pass the contents of its buffer to the processor 64.
The processor 64 acquires the decoded data packet from the RF PIC 82 and evaluates the content, which may include a command or information to be stored. In response to some data packets, the processor 64 may send a command to the ASIC 84 to change the power conditions on the RF receiver 80 or RF transceiver 81. The processor 64 also processes the commands and data received from the BG meter 10, which may result in controlling functions on the infusion pump 50. One of the main tasks for the ASIC 84 is to enable and disable power on the RF receiver 80 or RF transceiver 81. Generally, the ASIC 84 cycles the power on the RF receiver 80 or the RF transceiver 81 to save energy. If commanded by the processor 64, however, the ASIC 84 will enable the RF receiver 80 or the RF transceiver 81 to be powered continuously.
Each RF transmission sent to the infusion pump 50 preferably includes an RF signal header followed by a command packet or an information packet. Since the infusion pump'"'"'s RF receiver 80 or RF transceiver 81 is likely to wake up in the middle of a command packet, the RF signal header at the start of each transmission helps the infusion pump 50 to synchronize its data sampling and identify the first byte of a new command packet or information packet. The RF signal header is preferably the same for each transmission, and is transmitted at the start of each RF transmission.
The RF signal header may include two parts: a preamble and a start signature. The preamble is a series of pulses used to train the infusion pump'"'"'s digital signal sampling, and allows the infusion pump 50 to synchronize its pulse sampling with the pulse bits in the new transmission. The start signature notifies the RF PIC 82 when the first byte of a new packet is starting. Alternatively, the RF signal header may include other data, or the RF signal header may be omitted.
The command packets are 7 bytes in length, and information packets are 71 bytes in length. Alternative embodiments incorporate command packets and information packets of different lengths. The last byte of every command or information packet is an 8-bit cyclic redundancy check (CRC) calculated on all the preceding bytes in the packet. Before a command or information packet is transmitted to the infusion pump 50, it is preferably encoded by the BG meter 10 using a DC balanced encoding scheme, which translates 4 bits of data into 6 for transmission as follows:
The result of the encoding is that the 7-byte command packets require transmission of 11 bytes and the 71-byte information packets require transmission of 107 bytes. Upon receipt of the 1-byte or 107-byte packets from the BG meter 10, the RF PIC 82 in the infusion pump 50 decodes the packet into the 7-byte command packet or the 71-byte information packet. The processor 64 checks all packets for valid identification of the infusion pump 50 (e.g., identification or serial number) and CRC. If the infusion pump 50 identification is not valid, the packet is ignored. If the CRC of the first command packet is not valid, the command is ignored. Otherwise, the processor 64 may send a negative acknowledge (NAK) response to any packet with an invalid CRC.
Information packets (71 bytes) are much larger than command packets (7 bytes), and cannot be stored in the RF PIC 82, and thus, cannot be used to “wake up” the pump. Instead, a command packet must be sent to the infusion pump 50 to turn on the pump'"'"'s RF receiver 80 or RF transceiver 81 and prepare the pump 50 to receive an information packet. While power to the pump'"'"'s RF receiver 80 or RF transceiver 81 is being cycled, a command packet is repeatedly transmitted from the meter 10 to the pump 50 to activate the pump'"'"'s RF receiver 80 or RF transceiver 81. If an RF signal (i.e. including the first command packet) is present when the pump'"'"'s RF receiver 80 or RF transceiver 81 comes on, the pump 50 will attempt to store the contents of the signal in the RF PIC 82.
The processor 64 will verify whether the content of the signal is a valid command packet. If the command packet is valid, then the infusion pump 50 will stop power cycling and power the RF receiver 80 and RF transceiver 81 continuously. Only the first command packet must be transmitted repeatedly. After the RF receiver 80 or RF transceiver 81 is on full-time, other command packets or an information packet can be sent to the infusion pump 50.
The pump 50 preferably recognizes two categories of command packets: remote control or normal bolus commands and bolus estimation or amount commands. Remote control or normal bolus commands directly control the pump'"'"'s insulin bolus delivery. Bolus estimation or amount commands prepare the pump 50 to receive an information packet containing a new bolus estimate amount.
The pump 50 may receive a normal bolus command from the BG meter 10 or a remote programmer associated with the pump 50. The bolus command preferably includes a type code indicating the type of device transmitting the message (e.g., the BG meter 10 or the remote programmer), unique identifying information about the pump 50 (e.g., serial number, identification number, password, or the like), a key code indicating which bolus command button has been pressed (e.g., button “S” 22, button “B” 24, or button “ACT” 26 on the BG meter 10), and a counter indicating the number of times that the button has been pressed. In alternative embodiments, the bolus command may include other information and/or omit some of this data. When the pump 50 receives the bolus command, the processor 64 filters the command to discern the counter value so that the pump 50 can respond to the number of times the user has pressed the button to adjust a bolus.
The pump 50 may also receive a bolus estimation command from the BG meter 10. The bolus estimation command is transmitted to the pump 50 to prepare the pump 50 to receive an information packet containing a new bolus estimate amount from the BG meter 10. The bolus estimation command preferably includes a type code indicating the type of device transmitting the message (e.g., the BG meter 10), unique identifying information about the pump 50 (e.g., serial number, identification number, password, or the like), and a key code indicating that a new bolus estimate amount is about to be transmitted. In alternative embodiments, the bolus estimation command may include other information and/or omit some of this data.
In response to RF transmissions, the pump 50 typically sends an acknowledge (ACK) response. However, in particular embodiments, the BG meter 10 does not include an RF receiver, and the pump 50 does not include an RF transmitter, and thus, the pump 50 does not send an ACK response if the type code in the command (e.g., bolus or BG measurement command) indicates that the device transmitting the message is the BG meter 10. In alternative embodiments, both the BG meter 10 and the pump 50 may include an RF transceiver (i.e. transceiver 19 (shown in
When the infusion pump 50 receives a command packet from the BG meter 10, the processor 64 will send a data packet through the ASIC 84, commanding the RF receiver 80 or RF transceiver 81 to remain on full-time for a specified number of minutes, to receive other command packets or an information packet. The RF receiver 80 or RF transceiver 81 may return to power cycling after the information packet has been received, a certain period of time after receiving a command (in the event that the anticipated information packet does not arrive), or after the battery in the infusion pump 50 has been removed and replaced.
In an alternative embodiment, the BG meter 10 transmits only normal bolus commands and does not transmit the bolus estimation or amount commands. However, the BG meter 10 transmits the normal bolus commands as a series of commands over a predetermined time period, and this collectively approximates a bolus estimation or amount. The BG meter 10 accomplishes this by converting bolus estimation data into the series of normal bolus commands. Thus by doing so, for example, the SQUARE WAVE™ bolus can be approximated by a series of normal bolus commands transmitted over a predetermined time period that corresponds to the SQUARE WAVE™ bolus time period.
Generally, the infusion pump'"'"'s RF PIC 82 remains in receive mode unless it has received a command from the processor 64 to transmit, in which case it switches to transmit mode until the transmission is complete. Once the data has been transmitted, the RF PIC 82 automatically returns to receive mode.
Thus according to certain embodiments, there are disclosed methods and apparatuses relating to a physiological monitoring device that conducts a bolus estimation calculation. The monitoring device communicates a bolus amount resulting from the bolus estimation calculation to a medication infusion device, which delivers a bolus of medication to a user based on the communication from the monitoring device. The monitoring device may also be used to control other functions of the medication infusion device based on communications from the monitoring device.
While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention. The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the claims rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.